AXGN Q3 2024 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$49M+17.9% YoY

Gross Profit

$36M74.9% margin

Operating Income

-$316,000-0.6% margin

Net Income

-$2M-3.8% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$192M

Total Liabilities

$93M

Stockholders' Equity

$99M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$41M	+17.9%
Gross Profit	$36M	$32M	+14.9%
Operating Income	-$316,000	-$4M	+92.1%
Net Income	-$2M	-$4M	+54.6%